Abbott Targets Amneal In Latest Fight Over Generic Niaspan
Abbott Laboratories' AbbVie Inc. on Thursday hit Amneal Pharmaceuticals LLC with a patent suit in Delaware federal court, arguing that Amneal has infringed a patent covering its cholesterol medication Niaspan....To view the full article, register now.
Already a subscriber? Click here to view full article